Weiterführende Links zum Thema Medikationsfehler & Qualität
Interventionen durch Pharmazeuten (Klin. Pharmazie, Stationsapotheker) und Qualitätsverbesserung
Ahmad A et al. Effect of a Pharmacist Medication Review in Elderly Patients Discharged From the Hospital.
Arch Intern Med 2012;172(17):1346-7.
Alderman CP, Farmer C. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital.
J Qual Clin Pract 2001;21(4):99-103.
Al-Jazairi AS, Al-Agil AA, Asiri YA et al. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
Saudi Med J 2008;29(2):277-81.
Ariano RE, Demianczuk RH, Danzinger RG et al. Economic impact and clinical benefits of pharmacist involvement on surgical wards.
Can J Hosp Pharm 1995;48(5):284-9.
Aslani P, Rose G, Chen TF et al. A community pharmacist delivered adherence support service for dyslipidaemia.
Eur J Public Health 2011;21(5):567-72.
Avery AJ et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis.
Lancet 2012 Feb 20 e.
Bajorek BV, Krass I, Ogle SJ et al. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention.
J Am Geriatr Soc. 2005;53(11):1912-20.
Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
JAMA 1995;274(1):29-34.
Bayoumi I, Howard M, Holbrook AM et al. Interventions to improve medication reconciliation in primary care.
Ann Pharmacother 2009;43(10):1667-75.
Belknap SM. A ward-based pharmacist intervention reduced emergency department visits and drug-related readmissions in elderly patients.
Ann Intern Med 2009;151(6):JC3-14.
Bertsche T, Mayer Y, Stahl R et al. Prevention of intravenous drug incompatibilities in an intensive care unit.
Am J Health Syst Pharm 2008;65(19):1834-40.
Bertsche T et al. Prospective pilot intervention study to prevent medication errors in drugs administered to children by mouth or gastric tube: a programme for nurses, physicians and parents.
Qual Saf Health Care 2010;19(5):e15.
Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing.
Pharmacotherapy 2001;21(2):129-41.
Boyko WL Jr, Yurkowski PJ, Ivey MF et al.
Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital.
Am J Health Syst Pharm 1997;54(14):1591-5.
Bracey G, Miller G, Franklin BD et al. The contribution of a pharmacy admissions service to patient care.
Clin Med. 2008 Feb;8(1):53-7.
Bremberg ER, Hising C, Nylén U et al. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital
J Oncol Pharm Pract 2006;12(2):75-81.
Brookes K, Scott MG, McConnell JB. The benefits of a hospital based community services liaison pharmacist.
Pharm World Sci 2000;22(2):33-8.
Carter BL, Rogers M, Daly J et al. The potency of team-based care interventions for hypertension: a meta-analysis.
Arch Intern Med 2009;169(19):1748-55.
Carter MK, Allin DM, Scott LA et al. Pharmacist-acquired medication histories in a university hospital emergency department.
Am J Health Syst Pharm 2006;63(24):2500-3.
Carver PL, Lin SW, DePestel DD et al. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital.
J Clin Microbiol 2008;46(7):2381-3.
Casteel C, Blalock SJ, Ferreri S et al. Implementation of a Community Pharmacy-Based Falls Prevention Program.
Am J Geriatr Pharmacother 2011 Sep 16 e.
Charrois TL et al. A systematic review of the evidence for pharmacist care of patients with dyslipidemia.
Pharmacotherapy 2012;32(3):222-233.
Chisholm-Burns MA, Kim Lee J, Spivey CA et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses.
Med Care 2010;48(10):923-33.
Chisholm-Burns MA, Graff Zivin JS, Kim Lee J et al. Economic effects of pharmacists on health outcomes in the United States: A systematic review
Am J Health Syst Pharm 2010;67(19):1624-34.
Chisholm MA, Mulloy LL, Jagadeesan M et al. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients.
Ethn Dis 2002 ;12(3):392-7.
Chisholm MA, Mulloy LL, Jagadeesan M et al. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.
Clin Transplant 2001;15(5):330-6.
Colombo J. Establishing pharmaceutical care services in an HIV clinic.
J Am Pharm Assoc (Wash.) 1997;NS37(5):581-92.
Cohen V, Jellinek SP, Hatch A, Motov S. Effect of clinical pharmacists on care in the emergency department: a systematic review.
Am J Health Syst Pharm 2009;66(15):1353-61.
Dashti-Khavidaki S et al. The role of clinical pharmacist to improve medication administration through enteral feeding tubes by nurses.
Int J Clin Pharm 2012;34:757-64.
Davey P, Brown E, Fenelon L et al. Systematic review of antimicrobial drug prescribing in hospitals.
Emerg Infect Dis 2006;12(2):211-6.
Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients.
Cochrane Database Syst Rev 2005;(4):CD003543.
Desrochers JF, Lemieux JP, Morin-Bélanger C et al. Development and Validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) Criteria to Assess Medication Safety and Use Issues in Patients With CKD.
Am J Kidney Dis 2011;58(4):527-35.
Dranitsaris G, Spizzirri D, Pitre M et al. A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals.
Int J Technol Assess Health Care 2001;17(2):171-80.
Evans CD, Watson D, Eurich DT et al. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review.
Ann Pharmacother 2011;45(5):615-28 .
Fan T, Elgourt T. Pain management pharmacy service in a community hospital.
Am J Health Syst Pharm 2008;65(16):1560-5.
Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds.
Qual Saf Health Care 2005;14(3):207-11.
Fernandez-Llamazares CM, Calleja-Hernandez MA, Manrique-Rodriguez S et al. Impact of clinical pharmacist interventions in reducing paediatric prescribing errors.
Arch Dis Child. 2012 Feb 22 e.
Gardner B, Graner K. Pharmacists' medication reconciliation-related clinical interventions in a children's hospital.
Jt Comm J Qual Patient Saf 2009;35(5):278-82.
Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.
Arch Intern Med 1999;159(16):1939-45.
Geyer A, Ford MA, Rindone JP et al. The use of letter communication for patients enrolled in a pharmacist managed anticoagulation clinic.
J Clin Pharm Ther 2011;36(5):553-55.
Gillespie U, Alassaad A, Henrohn D et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.
Arch Intern Med 2009 ;169(9):894-900.
Hall WJ. Review: Pharmacist care improves therapeutic and safety outcomes in older adults.
Ann Intern Med 2013;159(10):JC6
Harrison DJ, Mitroka JG. Definig reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive health.
Ann Pharmacother 2011;45:115-19.
Hartmann M, Meier-Hellmann A. How to increase return on investment of the intensive care pharmacist - fear of flying.
Intensive Care Med 2006 ;32(4):511-5.
Hassan Y, Aziz NA, Awang J et al. An analysis of clinical pharmacist interventions in an intensive care unit.
J Clin Pharm Ther 1992;17(6):347-51.
Hayes BD, Donovan JL, Smith BS et al. Pharmacist-conducted medication reconciliation in an emergency department.
Am J Health Syst Pharm 2007 ;64(16):1720-3.
Heilmann RM et al. Impact of a pharmacist-directed intervention in postmenopausal women after fracture.
Am J Health Syst Pharm 2012;69(6):504-9.
Hellstrom LM, Bondesson A, Hoglund P et al. Errors in medication history at hospital admission: prevalence and predicting factors.
BMC Clinical Pharmacol 2012;12:9. (Volltext)
Holland R, Desborough J, Goodyer L et al.
Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis.
Br J Clin Pharmacol 2008;65(3):303-16.
Horn E, Jacobi J. The critical care clinical pharmacist: evolution of an essential team member.
Crit Care Med 2006;34(3 Suppl):S46-51.
Ibrahim KH, Gunderson B, Rotschafer JC. Intensive care unit antimicrobial resistance and the role of the pharmacist.
Crit Care Med 2001;29(4 Suppl):N108-13.
Isetts BJ, Brown LM, Schondelmeyer SW et al. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals.
Arch Intern Med 2003;163(15):1813-20.
Kaboli PJ et al. Clinical pharmacists and inpatient medical care: a systematic review.
Arch Intern Med 2006;166(9):955-64.
Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes.
Intensive Care Med 2003;29(5):691-8.
Khalili H et al. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
Eur J Intern Med 2013 Apr;24(3):227-33.
Khdour MR et al. Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD.
Intern J Clin Pharm 2011;33(4):665-673.
Khalili H, Farsaei S, Rezaee H et al. Role of clinical pharmacists' interventions in detection and prevention of medication errors in a medical ward.
Int J Clin Pharm 2011 Mar 12e.
Knibbe CA, Tjoeng MM. Clinical pharmacist on intensive care unit saves lives and reduces costs.
Crit Care Med 2008;36(12):3269-70.
Kopp BJ, Mrsan M, Erstad BL et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
Am J Health Syst Pharm 2007;64(23):2483-7.
Kripalani S, Roumie CL, Dalal AK et al (PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group). Effect of a pharmacist intervention on clinically important medication errors after hospital discharge. A randomized trial.
Ann Intern Med 2012;157(1):1-10.
Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
Crit Care Med 2002;30(4):919-21.
Kucukarslan SN, Peters M, Mlynarek M et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
Arch Intern Med. 2003 Sep 22;163(17):2014-8.
Kwan Y, Fernandes OA, Nagge JJ et al. Pharmacist medication assessments in a surgical preadmission clinic.
Arch Intern Med 2007;167(10):1034-40.
Lai PS, Chua SS, Chew YY et al. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
J Clin Pharm Ther 2011;36(5):557-67.
Langebrake C, Hilgarth H. Clinical pharmacists' interventions in a German university hospital.
Pharm World Sci. 2010 Apr;32(2):194-9. Epub 2010 Jan 19.
Lapane KL et al. Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.
Journal of the American Geriatrics Society 2011;59(7):1238-1245
Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
JAMA. 1999 ;282(3):267-70.
Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. ADE Prevention Study Group.
JAMA 1995;274(1):35-43.
Legris MÉ, Séguin NC, Desforges K et al. Pharmacist web-based training program on medication use in chronic kidney disease patients: Impact on knowledge, skills, and satisfaction.
J Contin Educ Health Prof 2011;31(3):140-50.
Lewis SM, Kroner BA. Patient survey of a pharmacist-managed anticoagulation clinic.
Manag Care Interface 1997;10(11):66-70.
López Cabezas C, Falces Salvador C, Cubí Quadrada D et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure.
Farm Hosp 2006;30(6):328-42.
Lowrie R et al (on behalf of the Heart FailurOptimal Outcomes from Pharmacy Study (HOOPS) Investigators). Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.
Eur Heart J 2011 Nov 14 e.
Lucas C, Glare PA, Sykes JV. Contribution of a liaison clinical pharmacist to an inpatient palliative care unit.
Palliat Med 1997;11(3):209-16.
Machado M, Bajcar J, Guzzo GC et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management.
Ann Pharmacother. 2007;41(10):1569-82.
Machado M, Nassor N, Bajcar JM et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management.
Ann Pharmacother 2008 ;42(9):1195-207.
Machado M, Bajcar J, Guzzo GC et al.
Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management.
Ann Pharmacother 2007;41(11):1770-81.
MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
Pharmacotherapy 2009;29(7):761-8.
MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections.
Crit Care Med 2008;36(12):3184-9.
Makowsky MJ, Schindel TJ, Rosenthal M et al. Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting.
J Interprof Care 2009;23(2):169-84.
Makowsky MJ, Koshman SL, Midodzi WK et al. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676].
Med Care 2009 Jun;47(6):642-50.
Malone DC, Carter BL, Billups SJ et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?
Med Care 2001;39(2):113-22.
Manley HJ, Cannella CA, Bailie GR et al. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis.
Am J Kidney Dis 2005;46(4):669-80.
Margolis KL, Bergdall AR, Asche SE et al. Outcomes at six months of a randomized trial of home blood pressure telemonitoring with pharmacist case management.
Quality of Care and Outcomes Research 2012 Scientific Sessions; Atlanta, GA; May 10, 2012. Presentation 7.
Marra C, Cibere J, Grubisic M et al. Pharmacist initiated intervention trial in osteoarthritis (PhIT-OA): A multidisciplinary intervention for knee osteoarthritis.
Arthritis Care Res (Hoboken) 2012 Aug 28 e .
Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay.
Crit Care Med. 2008 Feb;36(2):427-33.
McFarland M, Davis K, Wallace J et al. Use of Home Telehealth Monitoring with Active Medication Therapy Management by Clinical Pharmacists in Veterans with Poorly Controlled Type 2 Diabetes Mellitus.
Pharmacotherapy 2012 Apr 9 e.
McMullin ST, Hennenfent JA, Ritchie DJ et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.
Arch Intern Med 1999;159(19):2306-9.
Mehuys E, van Bortel L, De Bolle L et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
J Clin Pharm Ther 2011;36(5):602-613.
Milfred-LaForest SK et al. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.
Pharmacotherapy 2013;33(5):529-48.
Miller G, Franklin BD, Jacklin A et al. Including pharmacists on consultant-led ward rounds: a prospective non-randomised controlled trial.
Clin Med 2011;11(4):312-316.
Moffett BS, Mott AR, Nelson DP et al. Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation.
Pediatr Cardiol 2008;29(4):744-8.
Morgado MP, Morgado SR, Mendes LC et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis.
Am J Health Syst Pharm 2011;68(3):241-53.
Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists' clinical services.
Am J Health Syst Pharm 2001;58(7):569-77.
Mortimer C, Emmerton L, Lum E. The impact of an aged care pharmacist in a department of emergency medicine.
J Eval Clin Pract. 2011 Jun;17(3):478-85.
Mueller SK, Sponsler KC, Kripalani S et al. Hospital-Based Medication Reconciliation Practices:A Systematic Review.
Arch Intern Med 2012;172(14):1057-69.
Murphy EM, Oxencis CJ, Klauck JA et al. Medication reconciliation at an academic medical center: implementation of a comprehensive program from admission to discharge.
Am J Health Syst Pharm 2009;66(23):2126-31.
Nicol N. Case study: an interdisciplinary approach to medication error reduction.
Am J Health Syst Pharm 2007;64(14 Suppl 9):S17-20.
Nightingale G, Hajjar E, Swartz K et al. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
J Clin Oncol 2015 May 1;33(13):1453-9. (Volltext)
Novak CJ, Hastanan S, Moradi M et al. Case study: an interdisciplinary approach to medication error reduction.
Consult Pharm 2012;27(3):64(14 Suppl 9):S17-20.
Patel NP, Brandt CP, Yowler CJ. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary burn care team.
J Burn Care Res 2006;27(3):310-3.
Phansalkar S, Hoffman JM, Nebeker JR et al. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review.
Am J Health Syst Pharm 2007 ;64(8):842-9.
Phansalkar S, Hoffman JM, Hurdle JF et al. Understanding pharmacist decision making for adverse drug event (ADE) detection.
J Eval Clin Pract 2009;15(2):266-75.
Poon LH et al. Pharmacist's role in a Parkinson's disease and movement disorders clinic.
Am J Health Syst Pharm 2012;69(6):518-520.
Randolph TC et al. Effect of a pharmacist-managed culture review process on antimicrobial therapy in an emergency department.
Am J Health Syst Pharm 2011;68(10):916-9.
Randolph TC. Expansion of pharmacists' responsibilities in an emergency department.
Am J Health Syst Pharm 2009;66(16):1484-7.
Rothschild JM, Churchill W, Erickson A et al. Medication errors recovered by emergency department pharmacists.
Ann Emerg Med 2010;55(6):513-21.
Royal S, Smeaton L, Avery AJ et al. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis.
Qual Saf Health Care 2006 ;15(1):23-31.
Rubio-Valera M, Serrano-Blanco A, Magdalena-Belío J et al. Effectiveness of Pharmacist Care in the Improvement of Adherence to Antidepressants: A Systematic Review and Meta-Analysis.
Ann Pharmacother 2011;45:39-48.
Salgado TM et al. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review.
Nephrol Dial Transplant 2012;27(1):276-92.
Santschi V, Chiolero A, Burnand B et al. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
Arch Intern Med 2011;171:1441-53.
Sayles TJ. Documentation of pharmacists' interventions and associated cost savings.
Am J Health Syst Pharm 2004;61(8):838, 840.
Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting.
Ann Pharmacother 2006;40(9):1527-33.
Stemer G, Lemmens-Gruber R. Clinical pharmacy services and solid organ transplantation: a literature review.
Pharm World Sci 2010;32(1):7-18.
´
Stiegler KA, Yunker NS, Crouch MA. Effect of pharmacist counseling in patients hospitalized with acute exacerbation of asthma.
Am J Health Syst Pharm 2003;60(5):473-6.
Sweeney MA. Physician-pharmacist collaboration: a millennial paradigm to reduce medication errors.
J Am Osteopath Assoc 2002;102(12):678-81.
Tawadrous D, Shariff SZ, Haynes RB et al. Use of Clinical Decision Support Systems for Kidney-Related Drug Prescribing: A Systematic Review.
Am J Kidney Dis 2011 Sep 22 e.
To L, Schillig JM, DeSmet BD et al. Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management.
Ann Pharmacother 2011;45:195-200.
Tonna AP, Stewart D, West B et al. Antimicrobial optimisation in secondary care: the pharmacist as part of a multidisciplinary antimicrobial programme--a literature review.
Int J Antimicrob Agents 2008;31(6):511-7.
Tsuyuki RT, Al Hamarneh YN, Jones CA et al.The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
J Am Coll Cardiol 2016 Jun 21;67(24):2846-54.
Vasileff HM, Whitten LE, Pink JA et al. The effect on medication errors of pharmacists charting medication in an emergency department.
Pharm World Sci 2009;31(3):373-9.
Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes.
Basic Clin Pharmacol Toxicol 2008;102(3):275-80.
Vinks TH, Egberts TC, Lange TM et al. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial.
Drugs Aging 2009;26(2):123-33.
Vinks TH, de Koning FH, de Lange TM et al. Identification of potential drug related problems in the elderly: the role of the community pharmacist.
Pharm World Sci 2006;28(1):33-8
von Gunten V, Reymond JP, Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review.
Pharm World Sci 2007;29(3):146-63.
Wang JK, Herzog NS, Kaushal R et al. Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry.
Pediatrics 2007;119(1):e77-85.
Wallgren S, Berry-Caban CS, Bowers L. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.
Ann Pharmacother. 2012;46(3):353-7.
Wang HY, Chan AL, Chen MT et al. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics.
Transplant Proc 2008;40(7):2319-23.
Weant KA, Armitstead JA, Ladha AM et al. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
Neurosurgery 2009;65(5):946-50; discussion 950-1.
Weber CA, Ernst ME, Sezate GS et al. Pharmacist-Physician Comanagement of Hypertension and Reduction in 24-Hour Ambulatory Blood Pressures
Arch Intern Med 2010;170(18):1634-1639.
Wong YM, QuekYN, Tay JC et al. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration .
J Clin Pharm Ther 2011;36(5):585-91.
Wu JY et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial.
BMJ 2006;333(7567):522.
Young S, Bishop L, Twells L et al. Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic.
BMC Family Practice 17 Aug 2011 e.(Volltext)
Zhang C et al. Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial.
PLoS One 2012;7(1):e30856.
Wir befolgen denHONcode Standard für vertrauensvolle Gesundheitsinformationen.
Überprüfen Sie dies hier.
Pharmatrix erhielt 2002 den GSK-Preis für innovative Leistungen in der Krankenhauspharmazie